Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overt Diabetic Nephropathy”

17 trials

Showing 17 of 17 results

Post-approval studies (Phase 4)Ended earlyNCT00961207
What this trial is testing

Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric Patients

Who this might be right for
MicroalbuminuriaMacroalbuminuric Diabetic NephropathyDiabetes+2 more
Cook County Health 2
Post-approval studies (Phase 4)Study completedNCT00153023
What this trial is testing

1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

Who this might be right for
Diabetic NephropathiesHypertension
Boehringer Ingelheim 885
Post-approval studies (Phase 4)Study completedNCT00153088
What this trial is testing

INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Boehringer Ingelheim 527
Not applicableUnknownNCT02035891
What this trial is testing

Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria

Who this might be right for
Diabetic Nephropathy
Chongqing Medical University 160
Testing effectiveness (Phase 2)Study completedNCT00464776
What this trial is testing

Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 26
Testing effectiveness (Phase 2)Study completedNCT00160225
What this trial is testing

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Who this might be right for
Hypertension
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01200394
What this trial is testing

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathies
Pfizer 256
Post-approval studies (Phase 4)Study completedNCT00168857
What this trial is testing

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Who this might be right for
HypertensionDiabetic Nephropathies
Boehringer Ingelheim 860
Testing effectiveness (Phase 2)Study completedNCT00464880
What this trial is testing

Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy

Who this might be right for
Diabetes Type 2
Novartis 24
Not applicableStudy completedNCT00324675
What this trial is testing

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Who this might be right for
Type 2 DiabetesOvert Diabetic Nephropathy
Technische Universität Dresden 28
Large-scale testing (Phase 3)Study completedNCT00141453
What this trial is testing

ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial

Who this might be right for
Diabetic NephropathyType 2 Diabetes MellitusProteinuria
Daiichi Sankyo Co., Ltd. 577
Large-scale testing (Phase 3)Study completedNCT00556465
What this trial is testing

Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyChronic Kidney DiseaseDiabetes Type 2
Shiraz University of Medical Sciences 60
Post-approval studies (Phase 4)Study completedNCT00419835
What this trial is testing

Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes Mellitus

Who this might be right for
Macroalbuminuric Diabetic Nephropathy
University of Sao Paulo 80
Large-scale testing (Phase 3)UnknownNCT01067950
What this trial is testing

Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage Study

Who this might be right for
Type 1 Diabetes
Nantes University Hospital 180
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT01712061
What this trial is testing

Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Who this might be right for
Diabetic Nephropathy
Pfizer 226
Post-approval studies (Phase 4)Ended earlyNCT00130312
What this trial is testing

Effect of Sulodexide in Overt Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
Keryx Biopharmaceuticals 968

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation